Cargando…
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Several gene expression profiles with a strong correlation with patient outcomes have been previously described in chronic lymphocytic leukemia (CLL), although their applicability as biomarkers in clinical practice has been particularly limited. Here we describe the training and validation of a gene...
Autores principales: | Abrisqueta, Pau, Medina, Daniel, Villacampa, Guillermo, Lu, Junyan, Alcoceba, Miguel, Carabia, Julia, Boix, Joan, Tazón-Vega, Barbara, Iacoboni, Gloria, Bobillo, Sabela, Marín-Niebla, Ana, González, Marcos, Zenz, Thorsten, Crespo, Marta, Bosch, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647836/ https://www.ncbi.nlm.nih.gov/pubmed/35973197 http://dx.doi.org/10.1182/bloodadvances.2022007508 |
Ejemplares similares
-
Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
por: Jiménez, Isabel, et al.
Publicado: (2021) -
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
por: Bobillo, Sabela, et al.
Publicado: (2020) -
PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma
por: Ligero, Marta, et al.
Publicado: (2023) -
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition
por: Jiménez, Isabel, et al.
Publicado: (2020) -
Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia
por: Carabia, Júlia, et al.
Publicado: (2017)